4.6 Article

CD28 controls differentiation of regulatory T cells from naive CD4 T cells

期刊

JOURNAL OF IMMUNOLOGY
卷 181, 期 4, 页码 2285-2291

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.181.4.2285

关键词

-

资金

  1. NCI NIH HHS [R01 CA118116, R01 CA118116-01, R01 CA118116-02, CA 118116, R01 CA118116-03] Funding Source: Medline
  2. NIAID NIH HHS [R21 AI063553, R01 AI051693, R21 AI063553-01, AI 63553, AI 51693] Funding Source: Medline

向作者/读者索取更多资源

CD28 is required for the development of regulatory T cells (Tregs; CD4(+)CD25(+)Foxp3(+)) in the thymus and also contributes to their survival and homeostasis in the periphery. We studied whether and how CD28 and ICOS control the differentiation of Tregs from naive T cells. By using wild-type, CD28-, ICOS-, or CD28/ICOS-double knockout mice on C57BL/6 background as T cell sources, we found that CD28 is essential, whereas ICOS is dispensable, for the development and homeostasis of Tregs. Furthermore, the differentiation of Tregs from naive CD4(+)CD25(-) T cells in vivo also depends on CD28. The requirement of CD28 for Treg differentiation was mediated by IL-2, because neutralization of IL-2 with its specific mAb-blocked Treg differentiation from wild-type CD4(+)CD25(-) T cells and addition of IL-2 restored Treg differentiation from CD28(-/-) T cells. Other common gamma-chain cytokines, IL-4, IL-7, or IL-15, do not share such a role with IL-2. Although CD28 is required for the differentiation of Tregs from naive T cells, already generated Tregs do not depend on CD28 to exert their suppressive function. Our study reveals a new aspect of CD28 function in regulating T cell response.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Hematology

Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice

Anusara Daenthanasanmak, Supinya Iamsawat, Paramita Chakraborty, Hung D. Nguyen, David Bastian, Chen Liu, Shikhar Mehrotra, Xue-Zhong Yu

Article Oncology

Targeting PIM Kinase with PD1 Inhibition Improves Immunotherapeutic Antitumor T-cell Response

Shilpak Chatterjee, Paramita Chakraborty, Anusara Daenthanasanmak, Supinya Iamsawat, Gabriela Andrejeva, Libia A. Luevano, Melissa Wolf, Uday Baliga, Carsten Krieg, Craig C. Beeson, Meenal Mehrotra, Elizabeth G. Hill, Jeffery C. Rathmell, Xue-Zhong Yu, Andrew S. Kraft, Shikhar Mehrotra

CLINICAL CANCER RESEARCH (2019)

Article Immunology

Hippo Pathway Kinase Mst1 Is Required for Long-Lived Humoral Immunity

Sahar Bagherzadeh Yazdchi, Mariko Witalis, Alexandre P. Meli, Joanne Leung, Xin Li, Vincent Panneton, Jinsam Chang, Joanna Li, Stephen L. Nutt, Randy L. Johnson, Dae-Sik Lim, Hua Gu, Irah L. King, Woong-Kyung Suh

JOURNAL OF IMMUNOLOGY (2019)

Editorial Material Medicine, General & Internal

Modelling CAR-T therapy in humanized mice

Yongxia Wu, Xue-Zhong Yu

EBIOMEDICINE (2019)

Article Biochemistry & Molecular Biology

Thioredoxin-1 improves the immunometabolic phenotype of antitumor T cells

Paramita Chakraborty, Shilpak Chatterjee, Pravin Kesarwani, Krishnamurthy Thyagarajan, Supinya Iamsawat, Annika Dalheim, Hung Nguyen, Shanmugam P. Selvam, Patrick Nasarre, Gina Scurti, Gary Hardiman, Nilanjana Maulik, Lauren Ball, Vamsi Gangaraju, Mark P. Rubinstein, Nancy Klauber-DeMore, Elizabeth G. Hill, Besim Ogretmen, Xue-Zhong Yu, Michael I. Nishimura, Shikhar Mehrotra

JOURNAL OF BIOLOGICAL CHEMISTRY (2019)

Article Medicine, Research & Experimental

Thioredoxin-1 confines T cell alloresponse and pathogenicity in graft-versus-host disease

M. Hanief Sofi, Yongxia Wu, Steven D. Schutt, Min Dai, Anusara Daenthanasanmak, Jessica Heinrichs Voss, Hung Nguyen, David Bastian, Supinya Iamsawat, Shanmugam Panneer Selvam, Chen Liu, Nilanjana Maulik, Besim Ogretmen, Junfei Jin, Shikhar Mehrotra, Xue-Zhong Yu

JOURNAL OF CLINICAL INVESTIGATION (2019)

Review Immunology

The IL-12 Cytokine and Receptor Family in Graft-vs.-Host Disease

David Bastian, Yongxia Wu, Brian C. Betts, Xue-Zhong Yu

FRONTIERS IN IMMUNOLOGY (2019)

Review Immunology

Inducible T-cell co-stimulator: Signaling mechanisms in T follicular helper cells and beyond

Vincent Panneton, Jinsam Chang, Mariko Witalis, Joanna Li, Woong-Kyung Suh

IMMUNOLOGICAL REVIEWS (2019)

Article Cell Biology

The ICOS-ICOSL pathway tunes thymic selection

Mengqi Dong, Jinsam Chang, Marie-Eve Lebel, Noemie Gervais, Marilaine Fournier, Eve Mallet Gauthier, Woong-Kyung Suh, Heather J. Melichar

Summary: Negative selection is an important process for T-cell tolerance, and ICOS may play a role in fine-tuning T-cell receptor signals during thymic selection.

IMMUNOLOGY AND CELL BIOLOGY (2022)

Article Hematology

Leukemia inhibitory factor protects against graft-versus-host disease while preserving-versus-leukemia

Jianming Wang, Chun-Yuan Chang, Xue Yang, Fan Zhou, Juan Liu, Sining Zhu, Xue-Zhong Yu, Chen Liu, Timothy E. Sullivan, Ping Xie, Zhaohui Feng, Wenwei Hu

Summary: Recombinant LIF protein has been found to protect against tissue damage and mortality caused by GVHD without compromising graft-versus-leukemia activity. This protection is achieved by decreasing the infiltration and activation of immune cells and protecting intestinal stem cells through the activation of STAT1 signaling and downregulation of IL-12-p40 expression.
Article Immunology

ICOS-Deficient Regulatory T Cells Can Prevent Spontaneous Autoimmunity but Are Impaired in Controlling Acute Inflammation

Jinsam Chang, Antoine Bouchard, Yasser Bouklouch, Vincent Panneton, Joanna Li, Nikoletta Diamantopoulos, Saba Mohammaei, Roman Istomine, Fernando Alvarez, Ciriaco A. Piccirillo, Woong-Kyun Suh

Summary: ICOS is expressed in activated T cells and has a positive role in the differentiation and function of effector T cells. It is also expressed in a subpopulation of regulatory T cells and contributes to their homeostasis, migration, and function. However, tissue-protective Treg populations do not heavily rely on ICOS costimulation. In inflammatory conditions, ICOS has a dual positive role in both effector and Treg cells.

JOURNAL OF IMMUNOLOGY (2022)

Review Immunology

Hippo Signal Transduction Mechanisms in T Cell Immunity

Antoine Bouchard, Mariko Witalis, Jinsam Chang, Vincent Panneton, Joanna Li, Yasser Bouklouch, Woong-Kyung Suh

IMMUNE NETWORK (2020)

Article Hematology

Progression of AITL-like tumors in mice is driven by Tfh signature proteins and T-B cross talk

Mariko Witalis, Jinsam Chang, Ming-Chao Zhong, Yasser Bouklouch, Vincent Panneton, Joanna Li, Thorsten Buch, Seok Jin Kim, Won Seog Kim, Young Hyeh Ko, Andre Veillette, Woong-Kyung Suh

BLOOD ADVANCES (2020)

Article Hematology

Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse

Supinya Iamsawat, Linlu Tian, Anusara Daenthanasanmak, Yongxia Wu, Hung D. Nguyen, David Bastian, Xue-Zhong Yu

BLOOD ADVANCES (2019)

Article Medicine, Research & Experimental

Complement C3a and C5a receptors promote GVHD by suppressing mitophagy in recipient dendritic cells

Hung Nguyen, Sandeepkumar Kuril, David Bastian, Jisun Kim, Mengmeng Zhang, Silvia G. Vaena, Mohammed Dany, Min Dai, Jessica Lauren Heinrichs, Anusara Daenthanasanmak, Supinya Iamsawat, Steven Schutt, Jianing Fu, Yongxia Wu, David P. Fairlie, Carl Atkinson, Besim Ogretmen, Stephen Tomlinson, Xue-Zhong Yu

JCI INSIGHT (2018)

暂无数据